{
    "abstract": "Plasma estrogen measurement with use of radioimmunoassays has been instrumental in the development of aromatase inhibitors for endocrine therapy of postmenopausal breast cancer. However, due to low plasma estrogen concentrations in postmenopausal women, direct radioimmunoassays lack the sensitivity required. While certain laboratories have developed highly sensitive assays for research purposes revealing plasma estrogen suppression consistent with results from tracer studies, such assays are time and labor-consuming due to need for pre-analytical chromatographic purification, sample concentration and sometimes conversion of precursors to products. While novel chromatographic methods involving mass spectrometry analysis are likely to replace such radioimmunoassays in the future, so far a limited number of laboratories have developed suitable assays with a detection limit (around 1 pM) that is required for analyzing plasma estrogen levels in patients during treatment with potent aromatase inhibitors.",
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "William L.",
                    "initial": "W.L.",
                    "last": "McGuire"
                }
            ],
            "firstpage": "4289",
            "issn": "00085472",
            "lastpage": "4291",
            "pmid": "698967",
            "pub_year": 1978,
            "title": "Steroid Receptors in Human Breast Cancer",
            "volume": "38"
        },
        "b0015": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Cash"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Brough"
                },
                {
                    "first": "M. N.",
                    "initial": "M.N.",
                    "last": "Cohen"
                },
                {
                    "first": "P. S.",
                    "initial": "P.S.",
                    "last": "Satoh"
                }
            ],
            "doi": "10.1210/jcem-27-9-1239",
            "firstpage": "1239",
            "issn": "0021972X",
            "lastpage": "1248",
            "pmid": "4292247",
            "pub_year": 1967,
            "title": "Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.",
            "volume": "27"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Santen"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Lipton"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Kendall"
                }
            ],
            "doi": "10.1001/jama.1974.03240120029015",
            "firstpage": "1661",
            "issn": "00987484",
            "lastpage": "1665",
            "pmid": "4373589",
            "pub_year": 1974,
            "title": "Successful Medical Adrenalectomy With Amino-glutethimide: Role of Altered Drug Metabolism",
            "volume": "230"
        },
        "b0025": {
            "authors": [
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Samojlik"
                },
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Veldhuis"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Wells"
                },
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                }
            ],
            "doi": "10.1172/JCI109705",
            "firstpage": "602",
            "issn": "00219738",
            "lastpage": "612",
            "pmid": "6986409",
            "pub_year": 1980,
            "title": "Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma",
            "volume": "65"
        },
        "b0030": {
            "authors": [
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Santner"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Davis"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Veldhuis"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Samojlik"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Ruby"
                }
            ],
            "doi": "10.1210/jcem-47-6-1257",
            "firstpage": "1257",
            "issn": "0021972X",
            "lastpage": "1265",
            "pmid": "263348",
            "pub_year": 1978,
            "title": "Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma",
            "volume": "47"
        },
        "b0035": {
            "authors": [
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Worgul"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Lipton"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Harvey"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Boucher"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Samojlik"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Wells"
                }
            ],
            "doi": "10.7326/0003-4819-96-1-94",
            "firstpage": "94",
            "issn": "00034819",
            "lastpage": "101",
            "pub_year": 1982,
            "title": "Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma",
            "volume": "96"
        },
        "b0040": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1677/erc.0.0110179",
            "firstpage": "179",
            "issn": "13510088",
            "lastpage": "189",
            "pmid": "15163297",
            "pub_year": 2004,
            "title": "Aromatase inhibitors in breast cancer",
            "volume": "11"
        },
        "b0045": {
            "authors": [
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Santner"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Tilsen-Mallett"
                },
                {
                    "first": "H. R.",
                    "initial": "H.R.",
                    "last": "Rosen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Samojlik"
                },
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Veldhuis"
                }
            ],
            "issn": "00085472",
            "pmid": "7083200",
            "pub_year": 1982,
            "title": "In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor",
            "volume": "42"
        },
        "b0050": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Skulstad"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Sunde"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Thorsen"
                }
            ],
            "doi": "10.1016/0022-4731(89)90019-8",
            "firstpage": "91",
            "issn": "00224731",
            "lastpage": "97",
            "pmid": "2643736",
            "pub_year": 1989,
            "title": "Separation of urinary metabolites of radiolabelled estrogens in man by HPLC",
            "volume": "32"
        },
        "b0055": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Lonning"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jacobs"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Jones"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Haynes"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Powles"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1038/bjc.1991.175",
            "firstpage": "789",
            "issn": "00070920",
            "lastpage": "793",
            "pmid": "1828173",
            "pub_year": 1991,
            "title": "The influence of cgs 16949a on peripheral aromatisation in breast cancer patients",
            "volume": "63"
        },
        "b0060": {
            "authors": [
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Jones"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "MacNeill"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jacobs"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Lonning"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                }
            ],
            "doi": "10.1016/0959-8049(92)90074-C",
            "firstpage": "1712",
            "issn": "09598049",
            "lastpage": "1716",
            "pmid": "1389491",
            "pub_year": 1992,
            "title": "The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients",
            "volume": "28"
        },
        "b0065": {
            "authors": [
                {
                    "first": "F. A.",
                    "initial": "F.A.",
                    "last": "Macneill"
                },
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Jones"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jacobs"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Lonning"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1038/bjc.1992.339",
            "firstpage": "692",
            "issn": "00070920",
            "lastpage": "697",
            "pmid": "1419608",
            "pub_year": 1992,
            "title": "The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer",
            "volume": "66"
        },
        "b0070": {
            "authors": [
                {
                    "first": "F. A.",
                    "initial": "F.A.",
                    "last": "MacNeill"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jacobs"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Lonning"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                }
            ],
            "doi": "10.1007/BF00685855",
            "firstpage": "249",
            "issn": "03445704",
            "lastpage": "254",
            "pmid": "7781147",
            "pub_year": 1995,
            "title": "The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients",
            "volume": "36"
        },
        "b0075": {
            "authors": [
                {
                    "first": "F. A.",
                    "initial": "F.A.",
                    "last": "MacNeill"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jacobs"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00d8nning"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1038/bjc.1994.230",
            "firstpage": "1171",
            "issn": "00070920",
            "lastpage": "1175",
            "pmid": "8198987",
            "pub_year": 1994,
            "title": "Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: Effects on aromatase inhibition and oestrogen suppression",
            "volume": "69"
        },
        "b0080": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "King"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Ottestad"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Lundgren"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Walton"
                },
                {
                    "first": "P. O.",
                    "initial": "P.O.",
                    "last": "Kormeset"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1038/bjc.1996.531",
            "firstpage": "1286",
            "issn": "00070920",
            "lastpage": "1291",
            "pmid": "8883419",
            "pub_year": 1996,
            "title": "Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer",
            "volume": "74"
        },
        "b0085": {
            "authors": [
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "King"
                },
                {
                    "first": "Gun",
                    "initial": "G.",
                    "last": "Anker"
                },
                {
                    "first": "Giorgio",
                    "initial": "G.",
                    "last": "Ornati"
                },
                {
                    "first": "Enrico",
                    "initial": "E.",
                    "last": "Di Salle"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "firstpage": "2089",
            "issn": "10780432",
            "lastpage": "2093",
            "pmid": "9748124",
            "pub_year": 1998,
            "title": "In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients",
            "volume": "4"
        },
        "b0090": {
            "authors": [
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Ben",
                    "initial": "B.",
                    "last": "Haynes"
                },
                {
                    "first": "Gun",
                    "initial": "G.",
                    "last": "Anker"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1200/JCO.20.3.751",
            "firstpage": "751",
            "issn": "0732183X",
            "lastpage": "757",
            "pmid": "11821457",
            "pub_year": 2002,
            "title": "Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study",
            "volume": "20"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Cuzick"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Ingle"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Coates"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Forbes"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Bliss"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Buyse"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Baum"
                },
                {
                    "first": "Aman",
                    "initial": "A.",
                    "last": "Buzdar"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Colleoni"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Coombes"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Snowdon"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Gnant"
                },
                {
                    "first": "Raimund",
                    "initial": "R.",
                    "last": "Jakesz"
                },
                {
                    "first": "Manfred",
                    "initial": "M.",
                    "last": "Kaufmann"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Boccardo"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Godwin"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Davies"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Peto"
                }
            ],
            "doi": "10.1200/JCO.2009.23.1274",
            "firstpage": "509",
            "issn": "0732183X",
            "lastpage": "518",
            "pmid": "19949017",
            "pub_year": 2010,
            "title": "Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen",
            "volume": "28"
        },
        "b0100": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Lundgren"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Gundersen"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Klepp"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Lund"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Kvinnsland"
                }
            ],
            "doi": "10.1007/BF01810736",
            "firstpage": "201",
            "issn": "01676806",
            "lastpage": "206",
            "pmid": "2690972",
            "pub_year": 1989,
            "title": "Megestrol acetate versus aminoglutethimide for metastatic breast cancer",
            "volume": "14"
        },
        "b0105": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Helle"
                },
                {
                    "first": "N. K.",
                    "initial": "N.K.",
                    "last": "Duong"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ekse"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Aas"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Geisler"
                }
            ],
            "doi": "10.1016/j.jsbmb.2009.06.005",
            "firstpage": "31",
            "issn": "09600760",
            "lastpage": "41",
            "pmid": "19591931",
            "pub_year": 2009,
            "title": "Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status",
            "volume": "117"
        },
        "b0110": {
            "authors": [
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Harvey"
                }
            ],
            "doi": "10.1210/jcem-68-1-99",
            "firstpage": "99",
            "issn": "0021972X",
            "lastpage": "106",
            "pmid": "2521224",
            "pub_year": 1989,
            "title": "Inhibition of aromatase with CGS 16949A in postmenopausal women",
            "volume": "68"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Laurence M.",
                    "initial": "L.M.",
                    "last": "Demers"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Lipton"
                },
                {
                    "first": "Harold A.",
                    "initial": "H.A.",
                    "last": "Harvey"
                },
                {
                    "first": "Kathleen B.",
                    "initial": "K.B.",
                    "last": "Kambic"
                },
                {
                    "first": "Howard",
                    "initial": "H.",
                    "last": "Grossberg"
                },
                {
                    "first": "Carolyn",
                    "initial": "C.",
                    "last": "Brady"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Santen"
                }
            ],
            "doi": "10.1016/0960-0760(93)90283-3",
            "firstpage": "687",
            "issn": "09600760",
            "lastpage": "691",
            "pmid": "8476785",
            "pub_year": 1993,
            "title": "The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer",
            "volume": "44"
        },
        "b0120": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Goss"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Hutchinson"
                },
                {
                    "first": "A. M.H.",
                    "initial": "A.M.H.",
                    "last": "Brodie"
                },
                {
                    "first": "S. L.",
                    "initial": "S.L.",
                    "last": "Jeffcoate"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Coombes"
                }
            ],
            "firstpage": "1957",
            "issn": "00085472",
            "lastpage": "1961",
            "pmid": "3815384",
            "pub_year": 1987,
            "title": "Use of the Aromatase Inhibitor 4-Hydroxyandrostenedione in Postmenopausal Breast Cancer: Optimization of Therapeutic Dose and Route",
            "volume": "47"
        },
        "b0125": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Cunningham"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Stein"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Evans"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Dehennin"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Hedley"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Coombes"
                }
            ],
            "firstpage": "1306",
            "issn": "00085472",
            "lastpage": "1312",
            "pmid": "2917360",
            "pub_year": 1989,
            "title": "Dose-related Endocrine Effects and Pharmacokinetics of Oral and Intramuscular 4-Hydroxyandrostenedione in Postmenopausal Breast Gmcer Patients",
            "volume": "49"
        },
        "b0130": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "DOWSETT"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "STEIN"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "MEHTA"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "COOMBES"
                }
            ],
            "doi": "10.1111/j.1365-2265.1990.tb00906.x",
            "firstpage": "623",
            "issn": "03000664",
            "lastpage": "634",
            "pmid": "2142026",
            "pub_year": 1990,
            "title": "POTENCY AND SELECTIVITY OF THE NON\u2010STEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST CANCER PATIENTS",
            "volume": "32"
        },
        "b0135": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Macneill"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mehta"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Newton"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Haynes"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Jones"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Jarman"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Lonning"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Coombes"
                }
            ],
            "doi": "10.1038/bjc.1991.420",
            "firstpage": "887",
            "issn": "00070920",
            "lastpage": "894",
            "pmid": "1931611",
            "pub_year": 1991,
            "title": "Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (\u2018pyridoglutethimide\u2019) in postmenopausal breast cancer patients",
            "volume": "64"
        },
        "b0140": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mehta"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "King"
                },
                {
                    "first": "I. E.",
                    "initial": "I.E.",
                    "last": "Smith"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Powles"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Stein"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Coombes"
                }
            ],
            "doi": "10.1016/S0959-8049(05)80065-6",
            "firstpage": "415",
            "issn": "09598049",
            "lastpage": "420",
            "pmid": "1591054",
            "pub_year": 1992,
            "title": "An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients",
            "volume": "28"
        },
        "b0145": {
            "authors": [
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Iveson"
                },
                {
                    "first": "I. E.",
                    "initial": "I.E.",
                    "last": "Smith"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Ahern"
                }
            ],
            "firstpage": "266",
            "issn": "00085472",
            "lastpage": "270",
            "pmid": "8417819",
            "pub_year": 1993,
            "title": "Phase I Study of the Oral Nonsteroidal Aromatase Inhibitor CGS 20267 in Postmenopausal Patients with Advanced Breast Cancer",
            "volume": "53"
        },
        "b0150": {
            "authors": [
                {
                    "first": "J. Michael",
                    "initial": "J.M.",
                    "last": "Dixon"
                },
                {
                    "first": "Lorna",
                    "initial": "L.",
                    "last": "Renshaw"
                },
                {
                    "first": "Oliver",
                    "initial": "O.",
                    "last": "Young"
                },
                {
                    "first": "Juliette",
                    "initial": "J.",
                    "last": "Murray"
                },
                {
                    "first": "E. Jane",
                    "initial": "E.J.",
                    "last": "Macaskill"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "McHugh"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Folkerd"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Cameron"
                },
                {
                    "first": "Roger P.",
                    "initial": "R.P.",
                    "last": "A'Hern"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1200/JCO.2007.13.9279",
            "firstpage": "1671",
            "issn": "0732183X",
            "lastpage": "1676",
            "pmid": "18375896",
            "pub_year": 2008,
            "title": "Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer",
            "volume": "26"
        },
        "b0155": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ekse"
                }
            ],
            "doi": "10.1016/0960-0760(95)00180-8",
            "firstpage": "409",
            "issn": "09600760",
            "lastpage": "412",
            "pmid": "8541238",
            "pub_year": 1995,
            "title": "A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors",
            "volume": "55"
        },
        "b0160": {
            "authors": [
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Dagfinn",
                    "initial": "D.",
                    "last": "Ekse"
                },
                {
                    "first": "Hildegunn",
                    "initial": "H.",
                    "last": "Helle"
                },
                {
                    "first": "Nhat Kim",
                    "initial": "N.K.",
                    "last": "Duong"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1016/j.jsbmb.2007.12.011",
            "firstpage": "90",
            "issn": "09600760",
            "lastpage": "95",
            "pmid": "18242079",
            "pub_year": 2008,
            "title": "An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples",
            "volume": "109"
        },
        "b0165": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "Lonning"
                },
                {
                    "first": "S. I.",
                    "initial": "S.I.",
                    "last": "Helle"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Johannessen"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Adlercreutz"
                },
                {
                    "first": "E. A.",
                    "initial": "E.A.",
                    "last": "Lien"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tally"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ekse"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Fotsis"
                },
                {
                    "first": "G. B.",
                    "initial": "G.B.",
                    "last": "Anker"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Hall"
                }
            ],
            "doi": "10.1111/j.1365-2265.1995.tb02594.x",
            "firstpage": "23",
            "issn": "03000664",
            "lastpage": "30",
            "pmid": "7534218",
            "pub_year": 1995,
            "title": "Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients",
            "volume": "42"
        },
        "b0170": {
            "authors": [
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Hilgegunn",
                    "initial": "H.",
                    "last": "Helle"
                },
                {
                    "first": "Dagfinn",
                    "initial": "D.",
                    "last": "Ekse"
                },
                {
                    "first": "Nhat K.",
                    "initial": "N.K.",
                    "last": "Duong"
                },
                {
                    "first": "Dean B.",
                    "initial": "D.B.",
                    "last": "Evans"
                },
                {
                    "first": "Yngve",
                    "initial": "Y.",
                    "last": "Nordb\u00f8"
                },
                {
                    "first": "Turid",
                    "initial": "T.",
                    "last": "Aas"
                },
                {
                    "first": "Per E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1158/1078-0432.CCR-07-5221",
            "firstpage": "6330",
            "issn": "10780432",
            "lastpage": "6335",
            "pmid": "18829517",
            "pub_year": 2008,
            "title": "Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels",
            "volume": "14"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Karen Oerter",
                    "initial": "K.O.",
                    "last": "Klein"
                },
                {
                    "first": "Lawrence M.",
                    "initial": "L.M.",
                    "last": "Demers"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Santner"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Baron"
                },
                {
                    "first": "Gordon B.",
                    "initial": "G.B.",
                    "last": "Cutler"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Santen"
                }
            ],
            "doi": "10.1210/jcem.80.9.7673408",
            "firstpage": "2658",
            "issn": "0021972X",
            "lastpage": "2660",
            "pmid": "7673408",
            "pub_year": 1995,
            "title": "Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole",
            "volume": "80"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Dag Clement",
                    "initial": "D.C.",
                    "last": "Johannessen"
                },
                {
                    "first": "Terje",
                    "initial": "T.",
                    "last": "Engan"
                },
                {
                    "first": "Enrico",
                    "initial": "E.",
                    "last": "Di Salle"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Zurlo"
                },
                {
                    "first": "Jolanda",
                    "initial": "J.",
                    "last": "Paolini"
                },
                {
                    "first": "Giorgio",
                    "initial": "G.",
                    "last": "Ornati"
                },
                {
                    "first": "Gabriella",
                    "initial": "G.",
                    "last": "Piscitelli"
                },
                {
                    "first": "Stener",
                    "initial": "S.",
                    "last": "Kvinnsland"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "firstpage": "1101",
            "issn": "10780432",
            "lastpage": "1108",
            "pmid": "9815789",
            "pub_year": 1997,
            "title": "Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidai aromatase inhibitor, in postmenopausal breast cancer patients: A phase I study",
            "volume": "3"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Georg",
                    "initial": "G.",
                    "last": "Pfeiler"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "K\u00f6nigsberg"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Fesl"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Mlineritsch"
                },
                {
                    "first": "Herbert",
                    "initial": "H.",
                    "last": "Stoeger"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Singer"
                },
                {
                    "first": "Sabine",
                    "initial": "S.",
                    "last": "P\u00f6stlberger"
                },
                {
                    "first": "Guenther G.",
                    "initial": "G.G.",
                    "last": "Steger"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Seifert"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Dubsky"
                },
                {
                    "first": "Susanne",
                    "initial": "S.",
                    "last": "Taucher"
                },
                {
                    "first": "Hellmut",
                    "initial": "H.",
                    "last": "Samonigg"
                },
                {
                    "first": "Vesna",
                    "initial": "V.",
                    "last": "Bjelic-Radisic"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Greil"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Marth"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Gnant"
                }
            ],
            "doi": "10.1200/JCO.2010.33.2585",
            "firstpage": "2653",
            "issn": "0732183X",
            "lastpage": "2659",
            "pmid": "21555684",
            "pub_year": 2011,
            "title": "Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial",
            "volume": "29"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Ivana",
                    "initial": "I.",
                    "last": "Sestak"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Distler"
                },
                {
                    "first": "John F.",
                    "initial": "J.F.",
                    "last": "Forbes"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Howell"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Cuzick"
                }
            ],
            "doi": "10.1200/JCO.2009.27.2021",
            "firstpage": "3411",
            "issn": "0732183X",
            "lastpage": "3415",
            "pmid": "20547990",
            "pub_year": 2010,
            "title": "Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: An exploratory analysis from the ATAC trial",
            "volume": "28"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Marianne",
                    "initial": "M.",
                    "last": "Ewertz"
                },
                {
                    "first": "Kathryn P.",
                    "initial": "K.P.",
                    "last": "Gray"
                },
                {
                    "first": "Meredith M.",
                    "initial": "M.M.",
                    "last": "Regan"
                },
                {
                    "first": "Bent",
                    "initial": "B.",
                    "last": "Ejlertsen"
                },
                {
                    "first": "Karen N.",
                    "initial": "K.N.",
                    "last": "Price"
                },
                {
                    "first": "Beat",
                    "initial": "B.",
                    "last": "Th\u00fcrlimann"
                },
                {
                    "first": "Herv\u00e9",
                    "initial": "H.",
                    "last": "Bonnefoi"
                },
                {
                    "first": "John F.",
                    "initial": "J.F.",
                    "last": "Forbes"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Paridaens"
                },
                {
                    "first": "Manuela",
                    "initial": "M.",
                    "last": "Rabaglio"
                },
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Gelber"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Colleoni"
                },
                {
                    "first": "Istv\u00e1n",
                    "initial": "I.",
                    "last": "L\u00e1ng"
                },
                {
                    "first": "Ian E.",
                    "initial": "I.E.",
                    "last": "Smith"
                },
                {
                    "first": "Alan S.",
                    "initial": "A.S.",
                    "last": "Coates"
                },
                {
                    "first": "Aron",
                    "initial": "A.",
                    "last": "Goldhirsch"
                },
                {
                    "first": "Henning T.",
                    "initial": "H.T.",
                    "last": "Mouridsen"
                }
            ],
            "doi": "10.1200/JCO.2011.40.8666",
            "firstpage": "3967",
            "issn": "0732183X",
            "lastpage": "3975",
            "pmid": "23045588",
            "pub_year": 2012,
            "title": "Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial",
            "volume": "30"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Elizabeth J.",
                    "initial": "E.J.",
                    "last": "Folkerd"
                },
                {
                    "first": "J. Michael",
                    "initial": "J.M.",
                    "last": "Dixon"
                },
                {
                    "first": "Lorna",
                    "initial": "L.",
                    "last": "Renshaw"
                },
                {
                    "first": "Roger P.",
                    "initial": "R.P.",
                    "last": "A'Hern"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1200/JCO.2012.42.0273",
            "firstpage": "2977",
            "issn": "0732183X",
            "lastpage": "2980",
            "pmid": "22802308",
            "pub_year": 2012,
            "title": "Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer",
            "volume": "30"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "Benjamin P.",
                    "initial": "B.P.",
                    "last": "Haynes"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1016/j.ejca.2014.01.007",
            "firstpage": "1055",
            "issn": "09598049",
            "lastpage": "1064",
            "pmid": "24507547",
            "pub_year": 2014,
            "title": "Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors",
            "volume": "50"
        },
        "b0210": {
            "authors": [
                {
                    "first": "A. A.J.",
                    "initial": "A.A.J.",
                    "last": "van Landeghem"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Poortman"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Nabuurs"
                },
                {
                    "first": "J. H.H.",
                    "initial": "J.H.H.",
                    "last": "Thijssen"
                }
            ],
            "firstpage": "2907",
            "issn": "00085472",
            "lastpage": "2912",
            "pmid": "3986816",
            "pub_year": 1985,
            "title": "Endogenous Concentration and Subcellular Distribution of Androgens in Normal and Malignant Human Breast Tissue",
            "volume": "45"
        },
        "b0215": {
            "authors": [
                {
                    "first": "W. R.",
                    "initial": "W.R.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/0960-0760(91)90026-2",
            "firstpage": "783",
            "issn": "09600760",
            "lastpage": "790",
            "pmid": "1954167",
            "pub_year": 1991,
            "title": "Aromatase activity in breast tissue",
            "volume": "39"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Santner"
                },
                {
                    "first": "Donald",
                    "initial": "D.",
                    "last": "Leszczynski"
                },
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "Wright"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Manni"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Feil"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Santen"
                }
            ],
            "doi": "10.1007/BF01886734",
            "firstpage": "35",
            "issn": "01676806",
            "lastpage": "44",
            "pmid": "3457610",
            "pub_year": 1986,
            "title": "Estrone sulfate: A potential source of estradiol in human breast cancer tissues",
            "volume": "7"
        },
        "b0225": {
            "authors": [
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Hildegunn",
                    "initial": "H.",
                    "last": "Berntsen"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "doi": "10.1016/S0960-0760(00)00036-4",
            "firstpage": "259",
            "issn": "09600760",
            "lastpage": "264",
            "pmid": "10822015",
            "pub_year": 2000,
            "title": "A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue",
            "volume": "72"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Ju\u00a8rgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Simone",
                    "initial": "S.",
                    "last": "Detre"
                },
                {
                    "first": "Hildegunn",
                    "initial": "H.",
                    "last": "Berntsen"
                },
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "Ottestad"
                },
                {
                    "first": "Bernt",
                    "initial": "B.",
                    "last": "Lindtj\u00f8rn"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                },
                {
                    "first": "Per Eystein",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                }
            ],
            "firstpage": "1230",
            "issn": "10780432",
            "lastpage": "1236",
            "pmid": "11350888",
            "pub_year": 2001,
            "title": "Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer",
            "volume": "7"
        },
        "b0235": {
            "authors": [
                {
                    "first": "G. S.",
                    "initial": "G.S.",
                    "last": "Chetrite"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Cortes-Prieto"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Philippe"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Wright"
                },
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "Pasqualini"
                }
            ],
            "doi": "10.1016/S0960-0760(00)00040-6",
            "firstpage": "23",
            "issn": "09600760",
            "lastpage": "27",
            "pmid": "10731634",
            "pub_year": 2000,
            "title": "Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues",
            "volume": "72"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Ben P.",
                    "initial": "B.P.",
                    "last": "Haynes"
                },
                {
                    "first": "Anne Hege",
                    "initial": "A.H.",
                    "last": "Straume"
                },
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "A'Hern"
                },
                {
                    "first": "Hildegunn",
                    "initial": "H.",
                    "last": "Helle"
                },
                {
                    "first": "Ian E.",
                    "initial": "I.E.",
                    "last": "Smith"
                },
                {
                    "first": "Per E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1158/1078-0432.CCR-09-2481",
            "firstpage": "1790",
            "issn": "10780432",
            "lastpage": "1801",
            "pmid": "20215536",
            "pub_year": 2010,
            "title": "Intratumoral estrogen disposition in breast cancer",
            "volume": "16"
        },
        "b0245": {
            "authors": [
                {
                    "first": "A. A.",
                    "initial": "A.A.",
                    "last": "Larionov"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Berstein"
                },
                {
                    "first": "W. R.",
                    "initial": "W.R.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/S0960-0760(02)00047-X",
            "firstpage": "57",
            "issn": "09600760",
            "lastpage": "64",
            "pmid": "12127042",
            "pub_year": 2002,
            "title": "Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues",
            "volume": "81"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Anita K.",
                    "initial": "A.K.",
                    "last": "Dunbier"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Anderson"
                },
                {
                    "first": "Zara",
                    "initial": "Z.",
                    "last": "Ghazoui"
                },
                {
                    "first": "Elizabeth J.",
                    "initial": "E.J.",
                    "last": "Folkerd"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "A'Hern"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Crowder"
                },
                {
                    "first": "Jeremy",
                    "initial": "J.",
                    "last": "Hoog"
                },
                {
                    "first": "Ian E.",
                    "initial": "I.E.",
                    "last": "Smith"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Osin"
                },
                {
                    "first": "Ashutosh",
                    "initial": "A.",
                    "last": "Nerurkar"
                },
                {
                    "first": "Joel S.",
                    "initial": "J.S.",
                    "last": "Parker"
                },
                {
                    "first": "Charles M.",
                    "initial": "C.M.",
                    "last": "Perou"
                },
                {
                    "first": "Matthew J.",
                    "initial": "M.J.",
                    "last": "Ellis"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1200/JCO.2009.23.9616",
            "firstpage": "1161",
            "issn": "0732183X",
            "lastpage": "1167",
            "pmid": "20124184",
            "pub_year": 2010,
            "title": "Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women",
            "volume": "28"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Per E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "Ben P.",
                    "initial": "B.P.",
                    "last": "Haynes"
                },
                {
                    "first": "Anne H.",
                    "initial": "A.H.",
                    "last": "Straume"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Dunbier"
                },
                {
                    "first": "Hildegunn",
                    "initial": "H.",
                    "last": "Helle"
                },
                {
                    "first": "Stian",
                    "initial": "S.",
                    "last": "Knappskog"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1158/1078-0432.CCR-11-0043",
            "firstpage": "4948",
            "issn": "10780432",
            "lastpage": "4958",
            "pmid": "21791635",
            "pub_year": 2011,
            "title": "Exploring breast cancer estrogen disposition: The basis for endocrine manipulation",
            "volume": "17"
        },
        "b0260": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Kvinnsland"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Thorsen"
                },
                {
                    "first": "P. M.",
                    "initial": "P.M.",
                    "last": "Ueland"
                }
            ],
            "doi": "10.2165/00003088-198713060-00004",
            "firstpage": "393",
            "issn": "03125963",
            "lastpage": "406",
            "pmid": "3436111",
            "pub_year": 1987,
            "title": "Alterations in the Metabolism of Oestrogens During Treatment with Aminoglutethimide in Breast Cancer Patients: Preliminary Findings",
            "volume": "13"
        },
        "b0265": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Johannessen"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Thorsen"
                }
            ],
            "doi": "10.1038/bjc.1989.231",
            "firstpage": "107",
            "issn": "00070920",
            "lastpage": "111",
            "pmid": "2553085",
            "pub_year": 1989,
            "title": "Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with ainoglutethimide",
            "volume": "60"
        },
        "b0270": {
            "authors": [
                {
                    "first": "P. E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Geisler"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Johannessen"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ekse"
                }
            ],
            "doi": "10.1016/S0960-0760(96)00209-9",
            "firstpage": "255",
            "issn": "09600760",
            "lastpage": "260",
            "pmid": "9365198",
            "pub_year": 1997,
            "title": "Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate",
            "volume": "61"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Elizabeth J.",
                    "initial": "E.J.",
                    "last": "Folkerd"
                },
                {
                    "first": "Per E.",
                    "initial": "P.E.",
                    "last": "L\u00f8nning"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Dowsett"
                }
            ],
            "doi": "10.1200/JCO.2013.53.9411",
            "firstpage": "1396",
            "issn": "0732183X",
            "lastpage": "1400",
            "pmid": "24733806",
            "pub_year": 2014,
            "title": "Interpreting plasma estrogen levels in breast cancer: Caution needed",
            "volume": "32"
        },
        "b0280": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Santner"
                },
                {
                    "first": "P. D.",
                    "initial": "P.D.",
                    "last": "Feil"
                },
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Santen"
                }
            ],
            "doi": "10.1210/jcem-59-1-29",
            "firstpage": "29",
            "issn": "0021972X",
            "lastpage": "33",
            "pmid": "6725522",
            "pub_year": 1984,
            "title": "In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway",
            "volume": "59"
        }
    },
    "body_text": [
        {
            "endOffset": 21929,
            "parents": [],
            "secId": "s0025",
            "sentence": "In contrast, as estrone\u2013sulfate circulates at much higher levels, this steroid is usually in the detectable range in women receiving aromatase inhibitor therapy.",
            "startOffset": 21768,
            "title": "Discussion"
        },
        {
            "endOffset": 16552,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 16551,
                    "startOffset": 16547
                },
                "b0150": {
                    "endOffset": 16507,
                    "startOffset": 16500
                },
                "b0170": {
                    "endOffset": 16507,
                    "startOffset": 16500
                }
            },
            "secId": "s0015",
            "sentence": "Thus, two independent studies, both applying a cross-over design, have confirmed letrozole to be a more portent plasma estrogen suppressor as compared to anastrozole [30,34], consistent with tracer study findings [18].",
            "startOffset": 16334,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 14484,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 14483,
                    "startOffset": 14479
                }
            },
            "secId": "s0015",
            "sentence": "The procedure involved taking the samples through multiple purification steps (Fig. 1), hydrolysis and finally conversion of unconjugated E1 into E2 [31].",
            "startOffset": 14330,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 13422,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 13402,
                    "startOffset": 13398
                },
                "b0115": {
                    "endOffset": 13421,
                    "startOffset": 13417
                }
            },
            "secId": "s0015",
            "sentence": "Developing highly sensitive radioimmunoassays with a detection limit of about 1 pg/ml (3.7 pM), the Herhsey group revealed significant differences with respect to plasma estrogen suppression between the second-generation aromatase inhibitor CGS16949A [22] and letrozole [23].",
            "startOffset": 13147,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 19202,
            "parents": [],
            "refoffsets": {
                "b0255": {
                    "endOffset": 19201,
                    "startOffset": 19197
                }
            },
            "secId": "s0020",
            "sentence": "Based on these findings, we proposed a new hypothesis, explaining tissue to plasma hormone gradients based on physical\u2013chemical properties for each individual compound [51].",
            "startOffset": 19029,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 19336,
            "parents": [],
            "secId": "s0020",
            "sentence": "Considering unconjugated E2 and E1, these compounds are highly lipophilic, explaining a high tissue to plasma concentration gradient.",
            "startOffset": 19203,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 12703,
            "parents": [],
            "secId": "s0015",
            "sentence": "Tracer studies however are laborious and expensive to conduct and may be applied to small patient groups only.",
            "startOffset": 12593,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 14985,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 14908,
                    "startOffset": 14904
                },
                "b0165": {
                    "endOffset": 14984,
                    "startOffset": 14980
                }
            },
            "secId": "s0015",
            "sentence": "As for this assay, we achieved a detection limit of 0.67 pM for E2, 1.14 pM for E1 and 0.55 pM for E1S [32], a significant improvement as compared to our earlier 3H-based methods [33].",
            "startOffset": 14801,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 21454,
            "parents": [],
            "refoffsets": {
                "b0275": {
                    "endOffset": 21453,
                    "startOffset": 21449
                }
            },
            "secId": "s0025",
            "sentence": "Measurement of plasma estrogens in postmenopausal women, due to their low levels, are time- and labor-dependent methods, involving multiple steps such as chromatographic separation and conversion [55].",
            "startOffset": 21253,
            "title": "Discussion"
        },
        {
            "endOffset": 12056,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 11855,
                    "startOffset": 11852
                },
                "b0095": {
                    "endOffset": 12055,
                    "startOffset": 12051
                }
            },
            "secId": "s0010",
            "sentence": "Most importantly; these endocrine results were paralleled by clinical findings; while the 1st and 2nd generation compounds in general revealed clinical efficacy similar to tamoxifen [8], the three 3rd generation compounds revealed superiority, also with respect to clinical efficacy, and are today used as routine endocrine therapy for postmenopausal women in the adjuvant setting [19].",
            "startOffset": 11670,
            "title": "Tracer studies"
        },
        {
            "endOffset": 14157,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 14057,
                    "startOffset": 14053
                },
                "b0125": {
                    "endOffset": 14156,
                    "startOffset": 14149
                },
                "b0130": {
                    "endOffset": 14156,
                    "startOffset": 14149
                },
                "b0135": {
                    "endOffset": 14156,
                    "startOffset": 14149
                },
                "b0140": {
                    "endOffset": 14156,
                    "startOffset": 14149
                },
                "b0145": {
                    "endOffset": 14156,
                    "startOffset": 14149
                },
                "b0150": {
                    "endOffset": 14156,
                    "startOffset": 14149
                }
            },
            "secId": "s0015",
            "sentence": "The first sensitive 125I-based RIA for E2 measurement in patients treated with aromatase inhibitors was developed by Professor Mitch Dowsett at the Royal Marsden Hospital [24] and subsequently used to measure plasma E2 suppression with different aromatase inhibitors [25\u201330].",
            "startOffset": 13882,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 17386,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 17347,
                    "startOffset": 17343
                },
                "b0220": {
                    "endOffset": 17385,
                    "startOffset": 17381
                }
            },
            "secId": "s0020",
            "sentence": "Thus, issues have been raised with respect to local estrogen synthesis by aromatization [43] as well as de-conjugation of E1S [44].",
            "startOffset": 17255,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 17014,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 16751,
                    "startOffset": 16744
                },
                "b0190": {
                    "endOffset": 16751,
                    "startOffset": 16744
                },
                "b0195": {
                    "endOffset": 16751,
                    "startOffset": 16744
                },
                "b0200": {
                    "endOffset": 16833,
                    "startOffset": 16826
                },
                "b0205": {
                    "endOffset": 17013,
                    "startOffset": 17009
                }
            },
            "secId": "s0015",
            "sentence": "Conflicting data have challenged efficacy of aromatase inhibition for overweight/obese patients [37\u201339]; analyzing plasma estrogen levels with these sensitive radioimmunoassay\u2019s [40,41] revealed slightly higher plasma estrogen levels related to high BMI despite a similar degree of aromatase inhibition among overweight as compared to normal-weight individuals [41].",
            "startOffset": 16648,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 21253,
            "parents": [],
            "secId": "s0025",
            "sentence": "Further; recent studies applying radioimmunoassays have contributed to our understanding of estrogen disposition in general, including important topics like explaining elevated tissue to plasma estrogen levels.",
            "startOffset": 21043,
            "title": "Discussion"
        },
        {
            "endOffset": 12592,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 12591,
                    "startOffset": 12585
                },
                "b0095": {
                    "endOffset": 12447,
                    "startOffset": 12443
                },
                "b0100": {
                    "endOffset": 12591,
                    "startOffset": 12585
                }
            },
            "secId": "s0015",
            "sentence": "Thus, while randomized studies revealed superiority for third-generation aromatase inhibitors as compared to tamoxifen [19], in contrast first-and second-generation compounds were found of similar efficacy, but not superior, as compared to conventional therapy [8,20].",
            "startOffset": 12324,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 20432,
            "parents": [],
            "secId": "s0020",
            "sentence": "Thus, local synthesis would be of minor importance to local estrogen concentration, in as much as estrogens synthesized locally would be quickly buffered by the circulating pool of hormones.",
            "startOffset": 20242,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 22228,
            "parents": [],
            "secId": "s0025",
            "sentence": "While E1S may easily be hydrolyzed into unconjugated hormones, its potential contribution to tissue estrogen levels, based on arguments raised above, may be questioned.",
            "startOffset": 22060,
            "title": "Discussion"
        },
        {
            "endOffset": 19735,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 19524,
                    "startOffset": 19520
                },
                "b0260": {
                    "endOffset": 19734,
                    "startOffset": 19727
                },
                "b0265": {
                    "endOffset": 19734,
                    "startOffset": 19727
                }
            },
            "secId": "s0020",
            "sentence": "While the concentration of plasma E1S exceeds the concentration of circulating E1 and E2 by an average factor of 8 and 40, respectively [21], this is due to the fact that most unconjugated E2 and E1 are converted into E1S which, on the other hand, has a plasma clearance rate of only about 10% the clearance rate of the unconjugated estrogens [52,53].",
            "startOffset": 19384,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 15215,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 15069,
                    "startOffset": 15065
                },
                "b0170": {
                    "endOffset": 15214,
                    "startOffset": 15210
                }
            },
            "secId": "s0015",
            "sentence": "Applying this assay to patients on treatment with anastrozole versus letrozole [18], we recorded a mean suppression of plasma E2 of 92.8% versus 95.2%, for E1 96.3% versus 98.8%, and for E1S 95.3% versus 98.9%, respectively [34].",
            "startOffset": 14986,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 10031,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 9933,
                    "startOffset": 9930
                },
                "b0040": {
                    "endOffset": 10029,
                    "startOffset": 10026
                }
            },
            "secId": "s0005",
            "sentence": "While effective, aminoglutethimide treatment was associated with substantial side effects [7], for which reason much efforts were placed on developing novel, less toxic agents (see Ref. [8]).",
            "startOffset": 9840,
            "title": "Introduction"
        },
        {
            "endOffset": 21581,
            "parents": [],
            "secId": "s0025",
            "sentence": "The topic becomes complicated in particular when measuring estrogen levels in patients on treatment with aromatase inhibitors.",
            "startOffset": 21455,
            "title": "Discussion"
        },
        {
            "endOffset": 18708,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 18707,
                    "startOffset": 18700
                },
                "b0240": {
                    "endOffset": 18707,
                    "startOffset": 18700
                }
            },
            "secId": "s0020",
            "sentence": "However, tissue E2 and E1 levels correlated even stronger to their corresponding plasma estrogen concentrations [21,48].",
            "startOffset": 18588,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 19029,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 18860,
                    "startOffset": 18856
                },
                "b0250": {
                    "endOffset": 19028,
                    "startOffset": 19024
                }
            },
            "secId": "s0020",
            "sentence": "These findings are in agreement with the results from Professor Millers group revealing the bulk of tumor tissue estrogens to have a plasma origin [49] and the findings of Dunbier et al., reporting a strong correlation between postmenopausal plasma E2 levels and tumor tissue expression of estrogen-regulated genes [50].",
            "startOffset": 18709,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 10837,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 10687,
                    "startOffset": 10684
                }
            },
            "secId": "s0010",
            "sentence": "While tracer studies and plasma estrogen assessment in concert confirmed aminoglutethimide to act as a potent aromatase inhibitor in vivo [9], plasma estrogen radioimmunoassay\u2019s lacked the sensitivity to detect estrogen suppression >90%, which was what to expect based on the tracer results.",
            "startOffset": 10546,
            "title": "Tracer studies"
        },
        {
            "endOffset": 22610,
            "parents": [],
            "secId": "s0025",
            "sentence": "When considering tissue estrogen measurements, this becomes even more demanding, in general and requires pre-purification of samples by use of HPLC.",
            "startOffset": 22462,
            "title": "Discussion"
        },
        {
            "endOffset": 21767,
            "parents": [],
            "secId": "s0025",
            "sentence": "For example, patients on treatment with letrozole, the most potent aromatase inhibitor currently in clinical use, will frequently have estradiol levels below the level of detectability.",
            "startOffset": 21582,
            "title": "Discussion"
        },
        {
            "endOffset": 17793,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 17690,
                    "startOffset": 17683
                },
                "b0230": {
                    "endOffset": 17690,
                    "startOffset": 17683
                }
            },
            "secId": "s0020",
            "sentence": "Studying tumor tissue samples collected before and during treatment with anastrozole or letrozole [34,46], we confirmed effective tissue estrogen suppression with no evidence of \u201cescape\u201d for any single tumor.",
            "startOffset": 17585,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 15706,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 15636,
                    "startOffset": 15632
                }
            },
            "secId": "s0015",
            "sentence": "Another interesting approach was taken by Dr. Klein and her team who used an ultrasensitive recombinant cell bioassay to measure estrogen levels in patients on treatment with letrozole [35]; this approach is discussed in detail in another paper in this issue.",
            "startOffset": 15447,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 9651,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 9380,
                    "startOffset": 9377
                },
                "b0025": {
                    "endOffset": 9494,
                    "startOffset": 9491
                },
                "b0030": {
                    "endOffset": 9537,
                    "startOffset": 9534
                }
            },
            "secId": "s0005",
            "sentence": "While clinically efficient [4], subsequent studies by the Hershey group revealed sustained androgen production, despite estrogen suppression [5], a question solved when tracer studies [6] revealed that aminoglutethimide directly inhibited peripheral aromatization of androstenedione into estrone (E1).",
            "startOffset": 9350,
            "title": "Introduction"
        },
        {
            "endOffset": 18587,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 18586,
                    "startOffset": 18582
                }
            },
            "secId": "s0020",
            "sentence": "Interestingly, we confirmed elevated tumor E2 levels in estrogen receptor positive but not in estrogen receptor negative tumors; these elevated levels were found positively correlated to transcriptional levels of the estrogen receptor as well as the reductive 17 hydroxy steroid dehydrogenase B7, but negatively correlated to the oxidative B2 and B12 dehydrogenases [48].",
            "startOffset": 18216,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 18044,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 17875,
                    "startOffset": 17871
                }
            },
            "secId": "s0020",
            "sentence": "Further, studying tissue estrogens across benign and malignant breast tissue [21], we confirmed elevated tissue to plasma E2 as well as E1 gradients; as for benign tissue, the tissue to plasma ratio for E2 and E1 averaged about 2 and 5, respectively.",
            "startOffset": 17794,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 12780,
            "parents": [],
            "secId": "s0015",
            "sentence": "Thus, there is a need for simpler methods, like plasma estrogen measurement.",
            "startOffset": 12704,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 17254,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 17112,
                    "startOffset": 17108
                }
            },
            "secId": "s0020",
            "sentence": "Much interest has focused on issue estrogen levels since van Landeghem [42] and others three decades ago reported breast cancer tissue E2 levels a magnitude higher as compared to plasma levels in postmenopausal women.",
            "startOffset": 17037,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 11140,
            "parents": [],
            "secId": "s0010",
            "sentence": "With new aromatase inhibitor compounds in development, in collaboration with Professor Mitch Dowsett and his team, we initiated a program for in vivo assessment of aromatase inhibition.",
            "startOffset": 10955,
            "title": "Tracer studies"
        },
        {
            "endOffset": 20759,
            "parents": [],
            "secId": "s0025",
            "sentence": "This has been mandatory to development of aromatase inhibition, currently the major endocrine treatment option for postmenopausal breast cancer patients.",
            "startOffset": 20606,
            "title": "Discussion"
        },
        {
            "endOffset": 13755,
            "parents": [],
            "secId": "s0015",
            "sentence": "A problem related to use of 3H-labelled standards in radioimmunoassays relates to the limited specific activity of these standards (in the 50\u2013160 mCi/mmol range).",
            "startOffset": 13593,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 23571,
            "parents": [],
            "refoffsets": {
                "b0275": {
                    "endOffset": 23570,
                    "startOffset": 23566
                }
            },
            "secId": "s0025",
            "sentence": "While such methods are expected to continuously improve, notably, they should be subject to the same strict criteria documenting sensitivity and specificity in the low concentration range with reproducibility similar to what has been shown with respect to the most sensitive radioimmunoassay\u2019s [55].",
            "startOffset": 23272,
            "title": "Discussion"
        },
        {
            "endOffset": 13593,
            "parents": [],
            "secId": "s0015",
            "sentence": "Notably, as for both studies the difference in plasma estrogen suppression was corroborated by similar findings with respect to suppression of urinary estrogen secretion.",
            "startOffset": 13423,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 22461,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 22460,
                    "startOffset": 22456
                }
            },
            "secId": "s0025",
            "sentence": "Whether plasma E1S may be a significant contributor to tissue E2 or not, plasma E1S may be a good proxy parameter for estrogen suppression with potent aromatase inhibitors as it exist at equilibrium with unconjugated E1 and E2 [21].",
            "startOffset": 22229,
            "title": "Discussion"
        },
        {
            "endOffset": 13881,
            "parents": [],
            "secId": "s0015",
            "sentence": "A higher specific activity may be achieved with use of 125I-labelled compounds (specific activity in the 2000 Ci/mmol range).",
            "startOffset": 13756,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 17584,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 17583,
                    "startOffset": 17579
                }
            },
            "secId": "s0020",
            "sentence": "Using our sensitive radioimmunoassay\u2019s on tissue samples following HPLC purification (Fig. 2), we were able to detect tissue levels of E2 as well as E1 and E1S with high degree of sensitivity [45].",
            "startOffset": 17387,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 16013,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 16012,
                    "startOffset": 16008
                }
            },
            "secId": "s0015",
            "sentence": "Due to potential interacting metabolites, samples collected from patients on treatment with such compounds need pre-purification with use of HPLC before radio immunoassaying [36].",
            "startOffset": 15834,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 18215,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 18214,
                    "startOffset": 18210
                }
            },
            "secId": "s0020",
            "sentence": "As for E1S, however, we found a tissue to plasma gradient averaging 0.1 only, contrasting previous findings obtained by others with use of a direct radioimmunoassay [47].",
            "startOffset": 18045,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 12323,
            "parents": [],
            "secId": "s0015",
            "sentence": "The results from in vivo tracer studies, in concert with the results from large randomized studies, underline the imperative of maximal aromatase inhibition for optimal clinical efficacy.",
            "startOffset": 12136,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 15833,
            "parents": [],
            "secId": "s0015",
            "sentence": "A particular problem relates to plasma estrogen measurement for patients on steroidal aromatase inhibitors, such as exemestane.",
            "startOffset": 15706,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 20605,
            "parents": [],
            "secId": "s0025",
            "sentence": "Radioimmunoassay of plasma and tissue estrogen levels, in concert with tracer studies, has contributed significantly to our understanding of estrogen disposition.",
            "startOffset": 20443,
            "title": "Discussion"
        },
        {
            "endOffset": 11322,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 11199,
                    "startOffset": 11195
                },
                "b0055": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0060": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0065": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0070": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0075": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0080": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0085": {
                    "endOffset": 11321,
                    "startOffset": 11314
                },
                "b0090": {
                    "endOffset": 11321,
                    "startOffset": 11314
                }
            },
            "secId": "s0010",
            "sentence": "Using an HPLC method to separate estrogen metabolites [10], we developed an assay allowing assessment of in vivo aromatase inhibition with an average detection limit >99.1% [11\u201318].",
            "startOffset": 11141,
            "title": "Tracer studies"
        },
        {
            "endOffset": 10954,
            "parents": [],
            "secId": "s0010",
            "sentence": "Thus, direct assessment of in vivo aromatase inhibition by tracer studies were considered to be the \u201cgold standard\u201d.",
            "startOffset": 10838,
            "title": "Tracer studies"
        },
        {
            "endOffset": 10531,
            "parents": [],
            "secId": "s0005",
            "sentence": "Importantly, the successful implementation of aromatase inhibition as a major endocrine for breast cancer, from which more than a million breast cancer women around the world currently are benefitting, had not been possible without these careful translational studies applying sensitive radioimmunoassay\u2019s, in concert with tracer studies, to define the pharmacological mechanisms of action of aminoglutethimide and, thus, aromatase inhibition as a useful endocrine treatment option in breast cancer.",
            "startOffset": 10032,
            "title": "Introduction"
        },
        {
            "endOffset": 14655,
            "parents": [],
            "secId": "s0015",
            "sentence": "Taking this approach further, we improved our assay, allowing E1 as well as E1S to be converted into E2, each steroid to be measured with the same 125I-E2 assay (Table 2).",
            "startOffset": 14484,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 9839,
            "parents": [],
            "secId": "s0005",
            "sentence": "The discovery that aminoglutethimide executed its anti-tumor efficacy through aromatase inhibition had profound influence on subsequent development of endocrine therapy for breast cancer.",
            "startOffset": 9652,
            "title": "Introduction"
        },
        {
            "endOffset": 21042,
            "parents": [],
            "refoffsets": {
                "b0270": {
                    "endOffset": 20916,
                    "startOffset": 20909
                },
                "b0275": {
                    "endOffset": 21041,
                    "startOffset": 21037
                }
            },
            "secId": "s0025",
            "sentence": "In contrast, there have been many publications reporting plasma estrogen levels much higher than should be assumed based on theoretical calculations [54,55] and the need for caution with respect to critically interpreting the results in the literature cannot be overemphasized [55].",
            "startOffset": 20760,
            "title": "Discussion"
        },
        {
            "endOffset": 20241,
            "parents": [],
            "refoffsets": {
                "b0255": {
                    "endOffset": 20240,
                    "startOffset": 20236
                }
            },
            "secId": "s0020",
            "sentence": "However, the finding of similar tissue to plasma estrogen gradients in pre- and postmenopausal women despite substantial differences with respect to plasma estrogen levels between these groups indicate tissue to plasma equilibrium to be a rapid event [51].",
            "startOffset": 19985,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 12907,
            "parents": [],
            "secId": "s0015",
            "sentence": "A key problem relates to low plasma estrogen levels in postmenopausal women, in particular when on aromatase inhibitor therapy.",
            "startOffset": 12780,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 9069,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 8977,
                    "startOffset": 8974
                },
                "b0010": {
                    "endOffset": 9025,
                    "startOffset": 9022
                }
            },
            "secId": "s0005",
            "sentence": "While the history of endocrine therapy in breast cancer started more than a century ago, the scientific rationale arose with the discovery of [1] and confirmation of the predictive value of [2] the estrogen receptor (today known as ER\u03b1).",
            "startOffset": 8832,
            "title": "Introduction"
        },
        {
            "endOffset": 14800,
            "parents": [],
            "secId": "s0015",
            "sentence": "The approach involved adding minor amounts of 3H E2 as well as 3H E1 and 3H E1S for recovery standard including correction of the final results.",
            "startOffset": 14656,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 23271,
            "parents": [],
            "secId": "s0025",
            "sentence": "While different liquid and gas chromatographic methods over the years gradually have improved and should be expected to replace use of radioimmunoassays for research and, in particular, routine analysis in the future, it should be emphasized that, at this stage, there are only a few laboratories around the world with methods documented to have a detection limit allowing plasma estrogen assessment in patients on treatment with aromatase inhibitors.",
            "startOffset": 22820,
            "title": "Discussion"
        },
        {
            "endOffset": 19383,
            "parents": [],
            "secId": "s0020",
            "sentence": "In contrast, E1S is a water-soluble conjugate.",
            "startOffset": 19337,
            "title": "Tissue estrogen levels"
        },
        {
            "endOffset": 13146,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 13060,
                    "startOffset": 13056
                }
            },
            "secId": "s0015",
            "sentence": "Taking into account plasma levels of estradiol (E2), E1 and estrone sulfate (E1S) to be in the 15\u201320 pM, 70\u201380 pM and 4\u2013500 pM ranges, respectively [21], the assays need sensitivity limits of a few pM to detect potential suppression >98%.",
            "startOffset": 12908,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 16647,
            "parents": [],
            "secId": "s0015",
            "sentence": "Recently, data from the same studies have been analyzed with respect to body mass index (BMI).",
            "startOffset": 16553,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 22819,
            "parents": [],
            "secId": "s0025",
            "sentence": "Taken together, while reliable radioimmunoassays are available and have played an important role in translational research, such methods are too time- and labor-demanding to be functional for routine purposes.",
            "startOffset": 22610,
            "title": "Discussion"
        },
        {
            "endOffset": 22059,
            "parents": [],
            "refoffsets": {
                "b0280": {
                    "endOffset": 22058,
                    "startOffset": 22054
                }
            },
            "secId": "s0025",
            "sentence": "Due to its high plasma level, E1S has been considered a potential source for tissue estrogens through uptake and hydrolysis [56].",
            "startOffset": 21930,
            "title": "Discussion"
        },
        {
            "endOffset": 16333,
            "parents": [],
            "secId": "s0015",
            "sentence": "Apart from differentiating between first/second generation aromatase inhibitors on the one hand as compared to the highly potent third-generation compounds on the other side, plasma estrogen measurements have been able to discriminate also between highly potent third-generation compounds like anastrozole and letrozole.",
            "startOffset": 16013,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 9349,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 9233,
                    "startOffset": 9230
                }
            },
            "secId": "s0005",
            "sentence": "In parallel, introduction of what was known at that time as an adrenotoxic antiepileptic, aminoglutethimide, in an attempt to achieve a \u201cmedical adrenalectomy\u201d [3], indirectly led to introduction of aromatase inhibition as a successful endocrine therapy for postmenopausal women.",
            "startOffset": 9070,
            "title": "Introduction"
        },
        {
            "endOffset": 11669,
            "parents": [],
            "secId": "s0010",
            "sentence": "The results are depicted in Table 1; in brief, while most compounds (the so-called 1st and 2nd generation compounds) caused in vivo aromatase inhibition <90%, the three 3rd generation compounds; the steroidal inhibitor exemestane, as well as the non-steroidal compounds anastrozole and letrozole, each caused on average >98% aromatase inhibition.",
            "startOffset": 11323,
            "title": "Tracer studies"
        },
        {
            "endOffset": 14329,
            "parents": [],
            "secId": "s0015",
            "sentence": "Some years later, learning this assay for E2 measurement, we used the same 125I-E2 standard and E2 antibody developing a highly sensitive assay for plasma E1S measurement.",
            "startOffset": 14158,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 15447,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 15446,
                    "startOffset": 15442
                }
            },
            "secId": "s0015",
            "sentence": "It should be noted however that, even with this sensitive assay, 5 out of 12 patients had plasma levels of E2 below detection limit during anastrozole treatment; corresponding figures for letrozole was as high as 11 out of 12 [34].",
            "startOffset": 15216,
            "title": "Plasma estrogen measurements in relation to treatment with aromatase inhibitors"
        },
        {
            "endOffset": 19984,
            "parents": [],
            "secId": "s0020",
            "sentence": "Our hypothesis does not exclude local estrogen production; nor is it inconsistent with the finding that estrogen receptor expression as well as dehydrogenase activity to some degree may influence the ratio between E2 and E1 in breast cancer tissue.",
            "startOffset": 19736,
            "title": "Tissue estrogen levels"
        }
    ],
    "docId": "S0039128X14002013",
    "metadata": {
        "asjc": [
            "1303",
            "1308",
            "1310",
            "1312",
            "1605",
            "3004"
        ],
        "authors": [
            {
                "email": "per.lonning@helse-bergen.no",
                "first": "Per Eystein",
                "initial": "P.E.",
                "last": "L\u00f8nning"
            }
        ],
        "doi": "10.1016/j.steroids.2014.08.008",
        "firstpage": "26",
        "issn": "0039128X",
        "keywords": [
            "Aromatase",
            "Breast cancer",
            "Estradiol",
            "Estrogens",
            "Estrone",
            "Radioimmunoassay"
        ],
        "lastpage": "31",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "CHEM",
            "PHAR"
        ],
        "title": "Estradiol measurement in translational studies of breast cancer"
    }
}